NCT00440648 - Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

July 31, 2006

Conditions

Chronic Kidney Disease

Interventions

DRUG

sevelamer carbonate, sevelamer hydrochloride

Starting dose individualized for each patient and fixed daily dose throughout both treatment periods

DRUG

sevelamer hydrochloride, sevelamer carbonate

Starting dose individualized for each patient and fixed daily dose throughout both treatment periods

Trial Locations (15)

19045

Easton

19096

Wynnewood

23507

Norfolk

27157

Winston-Salem

36608

Mobile

37205

Nashville

39705

Columbus

46202

Indianapolis

46383

Valparaiso

60402

Berwyn

60445

Crestwood

63103

St Louis

63110

St Louis

80111

Greenwood Village

92501

Riverside

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY